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We conducted a randomised, double-blind, placebo-controlled study to evaluate the effectiveness of 
Viva QS® capsule, a supplement consisting of twelve herbs, for the management of nicotine addiction. 
Smokers meeting study criteria were recruited into the study. Follow-up was undertaken for 6 months, 
with three assessment time points for smoking status andwithdrawal symptoms. Brief counseling was 
provided at each follow-up via telephone call at week 4 and 12. At week 24, face-to-face follow-up was 
done and self-reported abstinence was validated by measuring expired carbon monoxide level and 
cotinine in urine and/or saliva samples. Result: Of 155 smokers recruited, mean age was 35.2 ± 8.36 
years. Mean baseline Fagerström test for nicotine dependence (FTND) score was 5.03 ± 1.39. 7-days 
point prevalence quit rate was 22.4% at week 24 [Viva QS = 30.7% vs. placebo = 13.9%]; p = 0.015; OR 
= 2.74 (CI =1.197-6.282), 34.7% at week 12 [42.7% vs. 26.2%; p = 0.038, OR = 2.08 (CI = 1.04-4.16) 
and 24.5% at week 12 [32% vs. 16.7%]; p =0.031; OR = 2.35 (CI = 1.07-5.17). Most common adverse 
events reported were sore throat (Viva QS =28.8% vs. placebo = 36.6%), dry mouth (17.8% vs. 16.9%) 
and cough (11% vs. 8.4%) There were no significant differences in all adverse events reported by subjects 
in both groups.   Conclusion: Viva QS ® at least doubled smoking cessation rate vs. placebo in smokers 
with moderate to high level ofnicotine dependence without any significant adverse effects. 
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Introduction: Different methods of slaughtering are being practiced because of differences in religious 
guidelines and environmental issues (use of electricity) or convenience of handling etc. Variation in 
methods of slaughtering results in different conditions namely, release of varying amount of blood and 
different degree of movement of its body parts prior to death. These issues are related to the release of 
neurotransmitter (NT) at the neuro-muscular junction (NMJ) eventually is subject to be released from the 
body through the blood flow. 
Experimental design: Muscle samples from chicken in small pieces were collected immediately after 
slaughtering. Slaughtering was carried out using sharp knife. Two different conditions pertaining to the 
Islamic guidelines of slaughtering were investigated. such as whether the neck was severed (S+) or not (S-
) from the body during slaughtering and whether the animal just after slaughtering was released (R+) or 
not (R-). The level of acetylecholine esterase mRNA involved in the degradation of acetylecholine, a NT 
at NMJ was investigated by RT-PCR. 
 Results: The level of acetylecholine esterase mRNA was not detected in the sample obtained from the 
chicken slaughtered following Islamic guidelines i.e., neck should not be severed and body should be 
released just after the slaughtering (R+S-). 
 Conclusions: Level of acetylcholine or acetylcholine esterase can be used as a biomarker to identify if 
the slaughtering is performed following Islamic guidelines. 
  
